These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 29879076)

  • 1. Primary central nervous system lymphoma in a patient with systemic lupus erythematosus mimicking high-grade glioma: A case report and review of literature.
    Su L; Ding M; Chen L; Li C; Lao M
    Medicine (Baltimore); 2018 Jun; 97(23):e11072. PubMed ID: 29879076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of primary central nervous system lymphoma in a systemic lupus erythematosus patient after treatment with mycophenolate mofetil and review of the literature.
    Balci MA; Pamuk GE; Unlu E; Usta U; Pamuk ON
    Lupus; 2017 Oct; 26(11):1224-1227. PubMed ID: 28152659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffuse large B-cell lymphoma of the central nervous system in mycophenolate mofetil-treated patients with systemic lupus erythematosus.
    Tsang HH; Trendell-Smith NJ; Wu AK; Mok MY
    Lupus; 2010 Mar; 19(3):330-3. PubMed ID: 19897521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary central nervous system lymphoma in neuropsychiatric systemic lupus erythematosus: case-based review.
    Ichikawa T; Shimojima Y; Kishida D; Kaneko T; Sekijima Y
    Rheumatol Int; 2021 May; 41(5):1009-1017. PubMed ID: 32253501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffuse large B-cell lymphoma of the central nervous system presenting as "lymphomatosis cerebri" and dementia in elderly man: Case report and review of the literature.
    Kerbauy MN; Pasqualin DDC; Smid J; Iquizli R; Kerbauy LN; Nitrini R; Ribas GC; Neder L; Hamerschlak N
    Medicine (Baltimore); 2019 Feb; 98(6):e14367. PubMed ID: 30732171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary central nervous system lymphoma in a patient with neuropsychiatric systemic lupus erythematosus receiving mycophenolate mofetil: A case report and literature review.
    Sakairi T; Nakasatomi M; Watanabe M; Hamatani H; Ikeuchi H; Kaneko Y; Handa H; Hiromura K
    Mod Rheumatol Case Rep; 2022 Jan; 6(1):36-40. PubMed ID: 34505624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salvage chemoimmunotherapy with rituximab, ifosfamide and etoposide (R-IE regimen) in patients with primary CNS lymphoma relapsed or refractory to high-dose methotrexate-based chemotherapy.
    Mappa S; Marturano E; Licata G; Frezzato M; Frungillo N; Ilariucci F; Stelitano C; Ferrari A; Sorarù M; Vianello F; Baldini L; Proserpio I; Foppoli M; Assanelli A; Reni M; Caligaris-Cappio F; Ferreri AJ
    Hematol Oncol; 2013 Sep; 31(3):143-50. PubMed ID: 23161567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Rare Case of Spontaneous Remission and Relapse of a Primary Central Nervous System Lymphoma.
    Ramos R; Fernandes JS; Almeida M; Almeida R
    Acta Med Port; 2018 Dec; 31(12):777-783. PubMed ID: 30684376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose chemotherapy and autologous stem cell transplant compared with conventional chemotherapy for consolidation in newly diagnosed primary CNS lymphoma--a randomized phase III trial (MATRix).
    Schorb E; Finke J; Ferreri AJ; Ihorst G; Mikesch K; Kasenda B; Fritsch K; Fricker H; Burger E; Grishina O; Valk E; Zucca E; Illerhaus G
    BMC Cancer; 2016 Apr; 16():282. PubMed ID: 27098429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus-negative, CD5-positive diffuse large B-cell lymphoma developing after treatment with oral tacrolimus for mixed connective tissue disease : a case report and review of the literature.
    Sekiguchi Y; Shimada A; Imai H; Wakabayashi M; Sugimoto K; Nakamura N; Sawada T; Komatsu N; Noguchi M
    J Clin Exp Hematop; 2012; 52(3):211-8. PubMed ID: 23269082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of primary CNS lymphoma (PCNSL) following successful treatment of systemic non-Hodgkin's lymphoma (NHL): a case series.
    Chamberlain MC
    J Neurooncol; 2013 May; 113(1):27-32. PubMed ID: 23456654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Primary central nervous system lymphoma in a patient with systemic lupus erythematosus].
    Pisoni CN; Grinberg AR; Plana JL; Freue RD; Manni JA; Paz L
    Medicina (B Aires); 2003; 63(3):221-3. PubMed ID: 12876906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphoma of the central nervous system originating from the septum pellucidum region: Two case reports with literature review.
    Chen D; Yan X; Lu L; Xue K; Dong X
    Medicine (Baltimore); 2023 Nov; 102(46):e35954. PubMed ID: 37986283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adrenal relapse of primary central nervous system diffuse large B-cell lymphoma: A case report.
    Ma S; Sen SS; Jug R; Zhang X; Zhang WL; Shen S; Yu CQ; Xu HT; Yang LH; Wang E
    Medicine (Baltimore); 2018 Sep; 97(38):e12482. PubMed ID: 30235749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary Central Nervous System Lymphoma in a Patient with Down Syndrome.
    Shibata A; Yamaguchi F; Sasaki K; Yokobori S; Morita A
    J Nippon Med Sch; 2023 Sep; 90(4):346-350. PubMed ID: 35644559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential development of multifocal recurrent non-Hodgkin's lymphoma of mucosa-associated lymphoid tissue and diffuse large B-Cell lymphoma in a single patient: A case report.
    Yang X; Min X; He W
    Medicine (Baltimore); 2018 May; 97(21):e10845. PubMed ID: 29794780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory brain lesions preceding primary central nervous system lymphoma: a case report and genetic analysis.
    XiaoHong Z; Shuo Y; GeHong D; AnChao Y; Ce W; YunYun D; Can W; SiJie H; Feng C; WenBin L
    Neurol Sci; 2023 May; 44(5):1555-1561. PubMed ID: 36599976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose chemotherapy with autologous stem-cell transplantation and hyperfractionated radiotherapy as first-line treatment of primary CNS lymphoma.
    Illerhaus G; Marks R; Ihorst G; Guttenberger R; Ostertag C; Derigs G; Frickhofen N; Feuerhake F; Volk B; Finke J
    J Clin Oncol; 2006 Aug; 24(24):3865-70. PubMed ID: 16864853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of post-therapy brain surveillance imaging in the detection of primary central nervous system lymphoma relapse.
    Fossard G; Ferlay C; Nicolas-Virelizier E; Rey P; Ducray F; Jouanneau E; Faurie P; Belhabri A; Sunyack MP; Chassagne-Clément C; Thiesse P; Sebban C; Biron P; Blay JY; Ghesquières H
    Eur J Cancer; 2017 Feb; 72():12-19. PubMed ID: 28012348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary Central Nervous System Lymphoma in an Immunocompetent Patient Presenting as Multiple Cerebellar Lesions: A Case Report and Review of Literature.
    Galarza Fortuna GM; Dvir K; Febres-Aldana C; Schwartz M; Medina AM
    J Investig Med High Impact Case Rep; 2019; 7():2324709619893548. PubMed ID: 31818145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.